OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Once-Weekly Semaglutide in Adolescents with Obesity
Daniel Weghuber, Timothy Barrett, Margarita Barrientos‐Pérez, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 24, pp. 2245-2257
Open Access | Times Cited: 348
Daniel Weghuber, Timothy Barrett, Margarita Barrientos‐Pérez, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 24, pp. 2245-2257
Open Access | Times Cited: 348
Showing 1-25 of 348 citing articles:
Comparing scientific abstracts generated by ChatGPT to original abstracts using an artificial intelligence output detector, plagiarism detector, and blinded human reviewers
Catherine A. Gao, Frederick M. Howard, Nikolay S. Markov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 332
Catherine A. Gao, Frederick M. Howard, Nikolay S. Markov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 332
Child and adolescent obesity
Natalie B. Lister, Louise A. Baur, Janine F. Felix, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Natalie B. Lister, Louise A. Baur, Janine F. Felix, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 224
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
Riccardo Nevola, Raffaella Epifani, Simona Imbriani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1703-1703
Open Access | Times Cited: 124
Riccardo Nevola, Raffaella Epifani, Simona Imbriani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1703-1703
Open Access | Times Cited: 124
Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials
Mihaela-Simona Popoviciu, Lorena Păduraru, Galal Yahya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10449-10449
Open Access | Times Cited: 103
Mihaela-Simona Popoviciu, Lorena Păduraru, Galal Yahya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10449-10449
Open Access | Times Cited: 103
New insights into the treatment of obesity
Matthias Blüher, Mohini Aras, Louis J. Aronne, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2058-2072
Closed Access | Times Cited: 85
Matthias Blüher, Mohini Aras, Louis J. Aronne, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2058-2072
Closed Access | Times Cited: 85
Childhood Obesity and Cardiovascular Disease Risk
Stephanie T. Chung, Andrea Krenek, Sheela N. Magge
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 7, pp. 405-415
Open Access | Times Cited: 66
Stephanie T. Chung, Andrea Krenek, Sheela N. Magge
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 7, pp. 405-415
Open Access | Times Cited: 66
Gut hormone co-agonists for the treatment of obesity: from bench to bedside
Rubén Nogueiras, Michael A. Nauck, Matthias H. Tschöp
Nature Metabolism (2023) Vol. 5, Iss. 6, pp. 933-944
Closed Access | Times Cited: 54
Rubén Nogueiras, Michael A. Nauck, Matthias H. Tschöp
Nature Metabolism (2023) Vol. 5, Iss. 6, pp. 933-944
Closed Access | Times Cited: 54
Adolescent PCOS: a postpubertal central obesity syndrome
Lourdes Ibáñez, Francis de Zegher
Trends in Molecular Medicine (2023) Vol. 29, Iss. 5, pp. 354-363
Open Access | Times Cited: 51
Lourdes Ibáñez, Francis de Zegher
Trends in Molecular Medicine (2023) Vol. 29, Iss. 5, pp. 354-363
Open Access | Times Cited: 51
Obesity-related kidney disease: Beyond hypertension and insulin-resistance
Tarek Ziad Arabi, Areez Shafqat, Belal Nedal Sabbah, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 45
Tarek Ziad Arabi, Areez Shafqat, Belal Nedal Sabbah, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 45
Fecal microbiota transplantation: current challenges and future landscapes
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 43
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 43
Medications for Obesity
Kimberly A. Gudzune, Robert F. Kushner
JAMA (2024) Vol. 332, Iss. 7, pp. 571-571
Closed Access | Times Cited: 40
Kimberly A. Gudzune, Robert F. Kushner
JAMA (2024) Vol. 332, Iss. 7, pp. 571-571
Closed Access | Times Cited: 40
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
Mansour Tobaiqy, Hajer Elkout
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 2, pp. 488-495
Open Access | Times Cited: 31
Mansour Tobaiqy, Hajer Elkout
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 2, pp. 488-495
Open Access | Times Cited: 31
Targeting the incretin system in obesity and type 2 diabetes mellitus
Saleem Ansari, Bernard Khoo, Tricia Tan
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 8, pp. 447-459
Closed Access | Times Cited: 29
Saleem Ansari, Bernard Khoo, Tricia Tan
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 8, pp. 447-459
Closed Access | Times Cited: 29
National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
Marie Ng, Xiaochen Dai, Rebecca M Cogen, et al.
The Lancet (2024)
Open Access | Times Cited: 27
Marie Ng, Xiaochen Dai, Rebecca M Cogen, et al.
The Lancet (2024)
Open Access | Times Cited: 27
Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk
Alexander Piening, E C Ebert, Carter Gottlieb, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Alexander Piening, E C Ebert, Carter Gottlieb, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis
Yulan Ma, Chun‐Yan Kong, Zhen Guo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Yulan Ma, Chun‐Yan Kong, Zhen Guo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality
Georgios Schoretsanitis, Stefan Weiler, Corrado Barbui, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2423385-e2423385
Open Access | Times Cited: 21
Georgios Schoretsanitis, Stefan Weiler, Corrado Barbui, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2423385-e2423385
Open Access | Times Cited: 21
Prevention of cardiorenal complications in people with type 2 diabetes and obesity
Daniel J. Drucker
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 338-353
Open Access | Times Cited: 19
Daniel J. Drucker
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 338-353
Open Access | Times Cited: 19
Pharmacotherapy for obesity: moving towards efficacy improvement
Walmir Coutinho, Bruno Halpern
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 18
Walmir Coutinho, Bruno Halpern
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 18
Obesity in Adolescents
Aaron S. Kelly, Sarah Armstrong, Marc P. Michalsky, et al.
JAMA (2024) Vol. 332, Iss. 9, pp. 738-738
Closed Access | Times Cited: 17
Aaron S. Kelly, Sarah Armstrong, Marc P. Michalsky, et al.
JAMA (2024) Vol. 332, Iss. 9, pp. 738-738
Closed Access | Times Cited: 17
Effect of Pediatric Obesity Treatment on Long-Term Health
Resthie R. Putri, Pernilla Danielsson, Nils Ekström, et al.
JAMA Pediatrics (2025)
Closed Access | Times Cited: 4
Resthie R. Putri, Pernilla Danielsson, Nils Ekström, et al.
JAMA Pediatrics (2025)
Closed Access | Times Cited: 4
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 2
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 2
Association of metabolic syndrome and chronic kidney disease
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 36
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 36
Semaglutide and cancer: A systematic review and meta-analysis
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 34
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 34
A Comprehensive Review on Weight Loss Associated with Anti-Diabetic Medications
Fatma Haddad, Ghadeer Dokmak, Maryam Bader, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1012-1012
Open Access | Times Cited: 33
Fatma Haddad, Ghadeer Dokmak, Maryam Bader, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1012-1012
Open Access | Times Cited: 33
